BackContineum Therapeutics Overview

Contineum Therapeutics Net Tangible Assets

Track Contineum Therapeutics's net tangible assets ($240M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$239.66M
39.83% YoYΔ $68.27M vs prior year quarter

Peer average

Loading

Contineum Therapeutics Net Tangible Assets History

Loading

Contineum Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Contineum Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Contineum Therapeutics (CTNM) FAQ

As of the most recent data (June 2026), CTNM shows a net tangible assets of $240M. That compares with $170M in the prior-year period — up 39.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTNM's net tangible assets is now $240M (was $170M) — a 39.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Contineum Therapeutics is outperforming or lagging.

Tracking CTNM's net tangible assets over time shows whether Contineum Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $170M in the prior-year period — up 39.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Contineum Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $240M) with ownership activity and broader fundamentals.